Could This Be the First Disease-Modifying Drug in Bronchiectasis?

By News Health
2 months Ago

(MedPage Today) — CHICAGO — Brensocatib (Brinsupri) appeared to have a disease-modifying effect on structural lung changes in non-cystic fibrosis bronchiectasis at its higher dose, a CT substudy of the ASPEN trial showed.
At the 25-mg dose…

Source link : https://www.medpagetoday.com/meetingcoverage/chest/118083

Author :

Publish date : 2025-10-22 17:20:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

How Were Cheese and Dementia Linked?

COVID Vaccination in Pregnancy; Breast Density Knowledge

The Holiday Misinformation Survival Guide

To Find Living Donors for Kidney Transplants, Pilot Program Turns to Social Networks

'Revolutionary' Change Needed to Address Intractable Healthcare Issue, Experts Say

'A Disgrace': Feds to Slash the Number of Recommended Vaccines, Reports Say